登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式(希尔记法):
C13H13BrClNO5
化学文摘社编号:
分子量:
378.60
UNSPSC Code:
12352204
PubChem Substance ID:
NACRES:
NA.32
MDL number:
产品名称
5-Bromo-4-chloro-3-indolyl β-D-ribofuranoside, ≥98.0% (HPLC)
SMILES string
OC[C@H]1O[C@@H](Oc2c[nH]c3ccc(Br)c(Cl)c23)[C@H](O)[C@@H]1O
InChI key
RYLVNYDICPAOQR-HUXSOILUSA-N
InChI
1S/C13H13BrClNO5/c14-5-1-2-6-9(10(5)15)7(3-16-6)20-13-12(19)11(18)8(4-17)21-13/h1-3,8,11-13,16-19H,4H2/t8-,11-,12-,13-/m1/s1
assay
≥98.0% (HPLC)
form
powder
optical activity
[α]/D -102.0±3.0°, c = 1 in methanol
storage temp.
−20°C
Quality Level
Application
Evaluation of novel beta-ribosidase substrates for the differentiation of Gram-negative bacteria
Packaging
Bottomless glass bottle. Contents are inside inserted fused cone.
Legal Information
Supplied by Glycosynth Limited, U.S. Patent No. 7,323,488, European Patent Nos. 1436411 and 1438424, for use only in internal research conducted by the purchaser. No rights under the aforementioned patents are conveyed which permit the resale, transfer, or use for purposes other than research. Rights under the aforementioned patents, for purposes other than internal research, may be obtained by contacting Glycosynth Limited.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
涉药品监管产品
此项目有
L A Butterworth et al.
Journal of applied microbiology, 96(1), 170-176 (2003-12-18)
To synthesize novel substrates for the detection of beta-ribosidase and assess their potential for the differentiation of Gram-negative bacteria. Two novel chromogenic substrates, 3',4'-dihydroxyflavone-4'-beta-D-ribofuranoside (DHF-riboside) and 5-bromo-4-chloro-3-indolyl-beta-D-ribofuranoside (X-riboside) were evaluated along with a known fluorogenic substrate, 4-methylumbelliferyl-beta-D-ribofuranoside (4MU-riboside). A total
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持